Logo image of PHG

KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis

USA - NYSE:PHG - US5004723038

28.17 USD
+0.15 (+0.54%)
Last: 11/5/2025, 12:47:28 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PHG. PHG was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While PHG is still in line with the averages on profitability rating, there are concerns on its financial health. PHG is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

PHG had positive earnings in the past year.
In the past year PHG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PHG reported negative net income in multiple years.
PHG had a positive operating cash flow in 4 of the past 5 years.
PHG Yearly Net Income VS EBIT VS OCF VS FCFPHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

With a decent Return On Assets value of 0.61%, PHG is doing good in the industry, outperforming 73.02% of the companies in the same industry.
Looking at the Return On Equity, with a value of 1.56%, PHG is in the better half of the industry, outperforming 73.55% of the companies in the same industry.
PHG has a Return On Invested Capital of 4.49%. This is in the better half of the industry: PHG outperforms 75.13% of its industry peers.
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROIC 4.49%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHG Yearly ROA, ROE, ROICPHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

PHG has a Profit Margin of 0.91%. This is in the better half of the industry: PHG outperforms 73.55% of its industry peers.
PHG has a better Operating Margin (6.11%) than 71.43% of its industry peers.
PHG's Operating Margin has declined in the last couple of years.
PHG's Gross Margin of 43.85% is on the low side compared to the rest of the industry. PHG is outperformed by 61.90% of its industry peers.
In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
Industry RankSector Rank
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHG Yearly Profit, Operating, Gross MarginsPHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

PHG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PHG has less shares outstanding
Compared to 5 years ago, PHG has more shares outstanding
The debt/assets ratio for PHG is higher compared to a year ago.
PHG Yearly Shares OutstandingPHG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHG Yearly Total Debt VS Total AssetsPHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 1.94 indicates that PHG is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of PHG (1.94) is better than 60.32% of its industry peers.
The Debt to FCF ratio of PHG is 19.41, which is on the high side as it means it would take PHG, 19.41 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 19.41, PHG is doing good in the industry, outperforming 70.90% of the companies in the same industry.
A Debt/Equity ratio of 0.69 indicates that PHG is somewhat dependend on debt financing.
PHG's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PHG is outperformed by 69.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Altman-Z 1.94
ROIC/WACC0.69
WACC6.5%
PHG Yearly LT Debt VS Equity VS FCFPHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

PHG has a Current Ratio of 1.26. This is a normal value and indicates that PHG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PHG (1.26) is worse than 80.42% of its industry peers.
PHG has a Quick Ratio of 1.26. This is a bad value and indicates that PHG is not financially healthy enough and could expect problems in meeting its short term obligations.
PHG has a Quick ratio of 0.81. This is amonst the worse of the industry: PHG underperforms 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.81
PHG Yearly Current Assets VS Current LiabilitesPHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

4

3. Growth

3.1 Past

PHG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.16%, which is quite good.
Measured over the past years, PHG shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
Looking at the last year, PHG shows a decrease in Revenue. The Revenue has decreased by -0.81% in the last year.
Measured over the past years, PHG shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%

3.2 Future

The Earnings Per Share is expected to grow by 12.68% on average over the next years. This is quite good.
PHG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.65% yearly.
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHG Yearly Revenue VS EstimatesPHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHG Yearly EPS VS EstimatesPHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.97 indicates a correct valuation of PHG.
Based on the Price/Earnings ratio, PHG is valued cheaper than 82.54% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.03. PHG is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.02, PHG is valued correctly.
Based on the Price/Forward Earnings ratio, PHG is valued cheaply inside the industry as 84.13% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.27, PHG is valued a bit cheaper.
Industry RankSector Rank
PE 16.97
Fwd PE 16.02
PHG Price Earnings VS Forward Price EarningsPHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 83.60% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHG indicates a somewhat cheap valuation: PHG is cheaper than 75.13% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 54.39
EV/EBITDA 12.61
PHG Per share dataPHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)71.43
PEG (5Y)N/A
EPS Next 2Y5.1%
EPS Next 3Y7.59%

5

5. Dividend

5.1 Amount

PHG has a Yearly Dividend Yield of 3.97%.
PHG's Dividend Yield is rather good when compared to the industry average which is at 1.90. PHG pays more dividend than 98.94% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, PHG pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.97%

5.2 History

The dividend of PHG decreases each year by -70.49%.
PHG has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
PHG Yearly Dividends per sharePHG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2025 0.5 1 1.5

5.3 Sustainability

0.62% of the earnings are spent on dividend by PHG. This is a low number and sustainable payout ratio.
DP0.62%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
PHG Yearly Income VS Free CF VS DividendPHG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B
PHG Dividend Payout.PHG Dividend Payout, showing the Payout Ratio.PHG Dividend Payout.PayoutRetained Earnings

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (11/5/2025, 12:47:28 PM)

28.17

+0.15 (+0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners47.54%
Inst Owner Change-3.19%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap27.13B
Revenue(TTM)18.02B
Net Income(TTM)162.00M
Analysts74.81
Price Target32.01 (13.63%)
Short Float %0.29%
Short Ratio3.6
Dividend
Industry RankSector Rank
Dividend Yield 3.97%
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-13 2025-05-13 (0.9673)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-1.89%
PT rev (3m)6.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.66%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE 16.97
Fwd PE 16.02
P/S 1.32
P/FCF 54.39
P/OCF 21.48
P/B 2.27
P/tB N/A
EV/EBITDA 12.61
EPS(TTM)1.66
EY5.89%
EPS(NY)1.76
Fwd EY6.24%
FCF(TTM)0.52
FCFY1.84%
OCF(TTM)1.31
OCFY4.66%
SpS21.31
BVpS12.39
TBVpS-2.02
PEG (NY)71.43
PEG (5Y)N/A
Graham Number21.51
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROCE 5.69%
ROIC 4.49%
ROICexc 4.97%
ROICexgc 16.33%
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
FCFM 2.43%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Debt/EBITDA 3.01
Cap/Depr 51.35%
Cap/Sales 3.72%
Interest Coverage 4
Cash Conversion 46.06%
Profit Quality 267.9%
Current Ratio 1.26
Quick Ratio 0.81
Altman-Z 1.94
F-Score8
WACC6.5%
ROIC/WACC0.69
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.16%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%0.5%
EPS Next Y0.24%
EPS Next 2Y5.1%
EPS Next 3Y7.59%
EPS Next 5Y12.68%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.14%
Revenue Next Year-1.93%
Revenue Next 2Y0.54%
Revenue Next 3Y1.79%
Revenue Next 5Y3.65%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%

KONINKLIJKE PHILIPS NVR- NY / PHG FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PHG.


What is the valuation status for PHG stock?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NVR- NY?

KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.


What are the PE and PB ratios of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

The Price/Earnings (PE) ratio for KONINKLIJKE PHILIPS NVR- NY (PHG) is 16.97 and the Price/Book (PB) ratio is 2.27.


What is the expected EPS growth for KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

The Earnings per Share (EPS) of KONINKLIJKE PHILIPS NVR- NY (PHG) is expected to grow by 0.24% in the next year.